From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.
The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.
Director Mark McDade reported a $3,250,000 purchase in Tourmaline Bio Inc $TRML.
Here’s The Hot Corner, with data through January 31, 2024:
In another Form 4, Daniela Mielke, director of The Bancorp Inc $TBBK, revealed a purchase of 3,315 shares.
Stay tuned. We’ll be back on Friday with more insider activity.
To have these insider transactions e-mailed to you every morning, sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team